Exelixis
EXEL
64.63
-1.20
-1.82%
Exelixis
US · EXEL
#1156 by market cap
Listed 1970
64.63
-1.20
-1.82%
Periodic snapshot; not a real-time feed.
· 2026-11-20 20:02
About Exelixis
Exelixis, Inc. is an oncology company, which focuses on discovering, developing, and commercialization of new medicines for difficult-to-treat cancers. Its products include cabometyx, cometriq, and cotellic. The company was founded by Stelios Papadopoulos on November 15, 1994, and is headquartered in Alameda, CA.
- Founded
- 1994
- CEO
- Dr. Michael M. Morrissey, PhD
- Employees
- 4,600
- Headquarters
- Alameda, California, United States of America
- Fiscal year end
- 01-01
- Website
- exelixis.com
Company profile
- Exchange
- US
- Symbol
- EXEL
- Market-cap rank
- #1156
- Listing date
- 1970-01-01
- Market cap
- 15.77B
- Float cap
- 13.56B
- Shares out
- 244.01M
- Float shares
- 209.78M
Sectors & themes
Quote time 2026-11-20 20:02:41 · For reference only, not investment advice and not tailored to your situation.
Exelixis discussion 0 comments